Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Healthcare Company (ACHC) Non-cash Items (2016 - 2025)

Acadia Healthcare Company (ACHC) has disclosed Non-cash Items for 15 consecutive years, with $395416.0 as the latest value for Q3 2025.

  • On a quarterly basis, Non-cash Items fell 94.96% to $395416.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $395416.0, a 94.96% decrease, with the full-year FY2024 number at $393416.0, up 12.7% from a year prior.
  • Non-cash Items was $395416.0 for Q3 2025 at Acadia Healthcare Company, down from $422610.0 in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $128.4 million in Q1 2025 to a low of $324409.0 in Q4 2021.
  • A 5-year average of $13.4 million and a median of $483160.5 in 2022 define the central range for Non-cash Items.
  • Peak YoY movement for Non-cash Items: tumbled 98.38% in 2023, then surged 28504.87% in 2025.
  • Acadia Healthcare Company's Non-cash Items stood at $324409.0 in 2021, then soared by 7380.99% to $24.3 million in 2022, then plummeted by 98.56% to $349080.0 in 2023, then increased by 12.7% to $393416.0 in 2024, then increased by 0.51% to $395416.0 in 2025.
  • Per Business Quant, the three most recent readings for ACHC's Non-cash Items are $395416.0 (Q3 2025), $422610.0 (Q2 2025), and $128.4 million (Q1 2025).